A weli defined cohort of coeliac patients was studied prospectively to assess the prevalence of coexisting thyroid disease and positive thyroid autoantibodies. Comparison with epidemiological data on the prevalence of coeliac disease in a neighbouring area suggested that few adult coeliac patients had been missed. Overall, 140% of the coeliac patients had thyroid disease: 10.3% were hypothyroid and 3.7% hyperthyroid, both significantly more than expected. There were significantly more coeliac disease patients with thyroid autoantibodies than expected -11% had thyroglobulin antibodies and 15% had thyroid microsomal antibodies. This association is clinically important. Three patients are described in whom the coexistence of coeliac disease and hypothyroidism led to diagnostic difficulties and delay of treatment. (Gut 1994; 35: 844-846) Case reports CASE 1 A 27 year old woman presented with constipation and menorrhagia. Investigation showed a normal haemoglobin (12 g/dl); mild iron deficiency, with a serum iron of 10 jimol/ (normal range 11-30 p,mol/l); and autoimmune hypothyroidism: thyroid stimulating hormone (TSH) 109 mU/l (normal range 0-4-5O0 mU/l), thyroxine T4 19 nmolI (normal range 70-155 nmol/1), thyroglobulin antibodies titre 1/640. She was started on thyroxine but despite adequate replacement therapy (TSH 1 2 mU/l) she lost 28 lb in weight and developed diarrhoea. Further investigation showed continued iron deficiency and new folate deficiency. Distal duodenal biopsy specimens showed subtotal villous atrophy and there was a noticeable clinical response to a gluten free diet. Repeat biopsies six months later confirmed significant histological improvement.
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An association between thyroid disease and coeliac disease has previously been described.' 2 These studied, however, have been retrospective, based on case note review, and have not attempted to investigate all coeliac disease patients within a defined population. They have not, therefore, been able to identify the true prevalence of thyroid disorders in coeliac disease. In addition, the clinical importance of this association has not been highlighted.
We have recently seen three patients in whom the coexistence of coeliac and thyroid disease led to diagnostic difficulties and apparent treatment failure. In the first patient, the symptoms of hypothyroidism masked those of coeliac disease; in the second chronic diarrhoea was thought to be a complication of thyroxine supplementation; and in the third a prior diagnosis of coeliac disease delayed the recognition of the symptoms of hypothyroidism.
These cases stimulated a prospective study to assess the prevalence of thyroid disorders within our cohort of 107 adult coeliac disease patients. These The results were analysed by calculating the standardised ratios (observed number/ expected number) for each category. The 95% confidence intervals were calculated using the exact Poisson calculation for standardised ratios from the BMJ Confidence Interval Analysis program. Where the confidence interval does not contain 1 00 the ratio can be regarded as significant.
Results
The results are shown in Tables I, II , and III. They were complete except for one female patient in whom the thyroid antibodies were unknown. They show a significantly greater proportion of coeliac patients with hypothyroidism (10-3%), hyperthyroidism (3.7%) and with both TG (11-22%) and TM (15%) autoantibodies than expected. The overall prevalence of 14% for overt thyroid disorder in patients with coeliac disease is of considerable clinical importance. The mean age of those with both coeliac and thyroid disease was significantly higher than that of those with just coeliac disease (53-8 years compared with 44'1 years: Student's t test, p<0000 1).
In 1 1 of the 15 patients with both diseases (eight with autoimmune hypothyroidism, three with hyperthyroid Graves's disease), the thyroid disease had presented first. All had received adequate treatment and were euthyroid at the time their coeliac disease was diagnosed. Three (two hypothyroid, one hyperthyroid) were found to have overt thyroid disease at the time their coeliac disease was diagnosed. All three had IgA anti-gliaden antibodies. They were each started on a gluten free diet at about the same time they received appropriate treatment for their thyroid disease. In one patient ( This suggests that our own prevalence of 73 per 100000 is reasonably accurate and that this study is therefore based on as complete a population of coeliac disease patients as possible. Untreated hypothyroidism and hyperthyroidism can both give rise to histological changes in the small bowel similar to those of coeliac disease,-7 making diagnosis difficult. These changes revert to normal, however, with adequate treatment of the thyroid disorder.47 Given that all except four of our patients were known to be euthyroid at the time their coeliac disease was diagnosed, we do not feel this biased our results. We also felt it reasonable to include the three patients in whom the thyroid and coeliac disease were diagnosed concurrently as all had IgA antigliaden antibodies. Unfortunately, no separate data exist on the prevalence of thyroid disease in the Forth Valley and therefore this information was calculated using data from the Whickham study in north east England.8 We felt this was reasonable, however, as two hospital based studies in Scotland have shown point prevalences of hyperthyroidism and hypothyroidism similar to those found in Whickham.9 10 We have therefore shown that the risk of overt thyroid disease, particularly hypothyroidism, in coeliac patients is greater than was previously believed. In addition, there was a greater than expected prevalence of thyroid antibodies, and a proportion of these patients will go on to develop overt hypothyroidism.11
This association between coeliac disease and autoimmune thyroid disease is not surprising given that the HLA haplotypes B8 and DR3 are found more commonly in both than in the general population. [12] [13] [14] The patients with both coeliac and thyroid disease were significantly older than those with coeliac disease alone. This may be simply because the prevalence of hypothyroidism increases with age.8 Another reason may be that the longer patients with coeliac disease remain untreated the more likely they are to develop autoimmune thyroid disease. Perhaps the abnormal small bowel mucosa allows excessive amounts of certain antigens to enter the circulation which cross react with thyroid antigens. Hence early detection of coeliac disease and commencement of a gluten free diet may reduce the risk of developing thyroid disorders. In our series only one of the 15 patients with coeliac and thyroid disease had been on a gluten free diet before the diagnosis of the thyroid disease, and then only for five months. This could be investigated further by assessing the prevalence of thyroid disorders in long term follow up of children with coeliac disease who were started on a gluten free diet early.
The association of coeliac disease and hypothyroidism is important clinically. Both diseases can present with lethargy, macrocytic anaemia, bowel disturbance, and malabsorption. Failure to recognise and treat both can therefore result in an apparent lack of response to treatment, as in the third patient presented here. There may, however, be clues to their coexistence such as the persistent macrocytosis in the face of normal haematinics, as in our patient 3. Untreated hypothyroidism can also mask the weight loss and diarrhoea of coeliac disease, as in the first case presented. These symptoms appeared only after thyroxine supplementation.
On the basis of our findings we suggest that thyroid function should be checked routinely in all coeliac patients at presentation, and rechecked if symptoms or a macrocytosis fail to respond to a gluten free diet. Similarly coeliac disease should be considered in hypothyroid patients who fail to respond to thyroxine or develop weight loss or diarrhoea. 
